ULK4: A Potential Drug Target for Various Diseases (G54986)

Target Name: ULK4

NCBI ID: G54986

ULK4

ULK4: A Potential Drug Target for Various Diseases

ULK4 (Unknown Little KRAB-associated gene 4) is a gene that has been identified as a potential drug target and biomarker for various diseases, including cancer. The gene is located on chromosome 6p21 and has been shown to be expressed in various tissues and organs, including the brain, spleen, and skeletal muscles.

The ULK4 gene has been associated with several diseases and conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. Studies have shown that ULK4 is involved in the development and progression of these diseases, and that it may play a role in the regulation of cellular processes that are important for disease progression.

One of the key functions of ULK4 is its role in the regulation of microtubule dynamics. Microtubules are important for the movement of cells and the transport of molecules within those cells. ULK4 has been shown to play a role in the regulation of microtubule stability and dynamics, which may be important for the proper functioning of cells.

In addition to its role in microtubule dynamics, ULK4 has also been shown to play a role in the regulation of actinin cytoskeleton. Actinin cytoskeleton is a protein that is involved in the regulation of cell shape and stability, and it is thought to play a role in the regulation of cell division and the development of cancer.

ULK4 has also been shown to be involved in the regulation of cell adhesion. Cell adhesion is the process by which cells stick together and form tissues, and it is an important factor in the development and maintenance of tissues and organs. ULK4 has been shown to play a role in the regulation of cell adhesion, which may be important for the development and maintenance of tissues and organs.

In addition to its role in cell structure and function, ULK4 has also been shown to play a role in the regulation of cellular signaling pathways.ULK4 has been shown to be involved in several signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway. These pathways are important for the regulation of cellular processes that are important for disease progression, and ULK4 may be a potential drug target for diseases that are characterized by the disruption of these pathways.

Overall, ULK4 is a gene that has been associated with a number of diseases and conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. Its role in the regulation of microtubule dynamics, actinin cytoskeleton, cell adhesion, and cellular signaling pathways suggests that it may be a potential drug target for diseases that are characterized by the disruption of these pathways. Further research is needed to determine the full role of ULK4 in disease progression and the development of new treatments.

Protein Name: Unc-51 Like Kinase 4

Functions: May be involved in the remodeling of cytoskeletal components, such as alpha-tubulin, and in this way regulates neurite branching and elongation, as well as cell motility

The "ULK4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ULK4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets